Former Trump Official Talks IRA Tweaks, Drug Shortages, Reference Pricing, March-In

Updated Story Joseph Grogan, who headed the Domestic Policy Council for the former Trump administration, tells Inside Health Policy it would be legislatively difficult to revise the Inflation Reduction Act due to Congressional Budget Office scoring, but he thinks there are several steps Donald Trump if reelected could take to make Medicare drug negotiations more transparent. He also expects Trump if president would revive his most favored nation drug pricing idea and says a GOP administration...